Nov. 14, 2016
Nov. 14, 2016. Aslan Pharmaceuticals, a biotech company focused on the development of immunotherapies and targeted agents for tumor types prevalent in Asia, and JHL Biotech, Asia’s premiere provider of contract manufacturing services for biologics, have announced a manufacturing services partnership. In accordance with the partnership agreement JHL will provide process development services to Aslan for the continued development of its ASLAN004 programme. Aslan will work with JHL to perform process development and manufacturing of ASLAN004, a fully human monoclonal antibody that blocks the signalling of the IL-4 and IL-13 receptors.